Jenny Roy

931 total citations
61 papers, 790 citations indexed

About

Jenny Roy is a scholar working on Genetics, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Jenny Roy has authored 61 papers receiving a total of 790 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Genetics, 27 papers in Molecular Biology and 22 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Jenny Roy's work include Estrogen and related hormone effects (33 papers), Hormonal Regulation and Hypertension (17 papers) and Pharmacogenetics and Drug Metabolism (11 papers). Jenny Roy is often cited by papers focused on Estrogen and related hormone effects (33 papers), Hormonal Regulation and Hypertension (17 papers) and Pharmacogenetics and Drug Metabolism (11 papers). Jenny Roy collaborates with scholars based in Canada, Russia and Mexico. Jenny Roy's co-authors include Donald Poirier, René Maltais, Diana Ayán, Patrick DeRoy, Martin Perreault, Fernand Labrie, Tudor Roşu, Bernard Candas, Vitalie Stavila and Claude Labrie and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Jenny Roy

59 papers receiving 777 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jenny Roy Canada 17 338 333 250 181 123 61 790
René Maltais Canada 20 561 1.7× 599 1.8× 316 1.3× 349 1.9× 72 0.6× 84 1.1k
Mathias Färnegårdh Sweden 13 378 1.1× 531 1.6× 105 0.4× 210 1.2× 275 2.2× 14 1.1k
Michael L. Mohler United States 19 269 0.8× 419 1.3× 218 0.9× 416 2.3× 108 0.9× 31 1.1k
Shankar M. Singh Canada 16 227 0.7× 314 0.9× 330 1.3× 155 0.9× 52 0.4× 33 826
Nigel Vicker United Kingdom 25 405 1.2× 666 2.0× 878 3.5× 392 2.2× 92 0.7× 48 1.7k
Martin Frotscher Germany 19 722 2.1× 390 1.2× 359 1.4× 686 3.8× 46 0.4× 46 1.2k
Tadas S. Vasaitis United States 19 384 1.1× 525 1.6× 192 0.8× 307 1.7× 86 0.7× 21 1.1k
Mark Salvati United States 15 357 1.1× 399 1.2× 191 0.8× 359 2.0× 174 1.4× 48 1.0k
Cecil H. Robinson United States 14 524 1.6× 432 1.3× 201 0.8× 84 0.5× 92 0.7× 39 990
Raju Mohan United States 19 204 0.6× 647 1.9× 579 2.3× 60 0.3× 219 1.8× 35 1.3k

Countries citing papers authored by Jenny Roy

Since Specialization
Citations

This map shows the geographic impact of Jenny Roy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jenny Roy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jenny Roy more than expected).

Fields of papers citing papers by Jenny Roy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jenny Roy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jenny Roy. The network helps show where Jenny Roy may publish in the future.

Co-authorship network of co-authors of Jenny Roy

This figure shows the co-authorship network connecting the top 25 collaborators of Jenny Roy. A scholar is included among the top collaborators of Jenny Roy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jenny Roy. Jenny Roy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Poirier, Donald, René Maltais, Jacques Rousseau, et al.. (2022). Chemical synthesis of fluorinated and iodinated 17β-HSD3 inhibitors and evaluation for imaging prostate cancer tumors and tissue biodistribution. Bioorganic Chemistry. 129. 106145–106145. 4 indexed citations
5.
6.
Maltais, René, et al.. (2020). Synthesis of 17β-hydroxysteroid dehydrogenase type 10 steroidal inhibitors: Selectivity, metabolic stability and enhanced potency. European Journal of Medicinal Chemistry. 209. 112909–112909. 12 indexed citations
7.
Roy, Jenny, et al.. (2020). Insight into the Mechanism of 17β-Hydroxysteroid Dehydrogenase Type 3 Inhibition by the Androsterone Derivative RM-532-105. Current Enzyme Inhibition. 16(3). 243–250. 3 indexed citations
8.
Maltais, René, Martin Perreault, Jenny Roy, & Donald Poirier. (2019). Minor chemical modifications of the aminosteroid derivative RM-581 lead to major impact on its anticancer activity, metabolic stability and aqueous solubility. European Journal of Medicinal Chemistry. 188. 111990–111990. 7 indexed citations
9.
Roy, Jenny, et al.. (2018). Identification of steroidal derivatives inhibiting the transformations of allopregnanolone and estradiol by 17β-hydroxysteroid dehydrogenase type 10. Bioorganic & Medicinal Chemistry Letters. 28(22). 3554–3559. 12 indexed citations
10.
11.
Maltais, René, et al.. (2017). Pharmacokinetic profile of PBRM in rodents, a first selective covalent inhibitor of 17β-HSD1 for breast cancer and endometriosis treatments. The Journal of Steroid Biochemistry and Molecular Biology. 178. 167–176. 13 indexed citations
12.
Ayán, Diana, et al.. (2015). The Aminosteroid Derivative RM-133 Shows In Vitro and In Vivo Antitumor Activity in Human Ovarian and Pancreatic Cancers. PLoS ONE. 10(12). e0144890–e0144890. 17 indexed citations
13.
14.
Roy, Jenny, et al.. (2014). In vitro and in vivo evaluation of a 3β-androsterone derivative as inhibitor of 17β-hydroxysteroid dehydrogenase type 3. The Journal of Steroid Biochemistry and Molecular Biology. 141. 44–51. 10 indexed citations
15.
Ayán, Diana, René Maltais, Jenny Roy, & Donald Poirier. (2012). A New Nonestrogenic Steroidal Inhibitor of 17β-Hydroxysteroid Dehydrogenase Type I Blocks the Estrogen-Dependent Breast Cancer Tumor Growth Induced by Estrone. Molecular Cancer Therapeutics. 11(10). 2096–2104. 40 indexed citations
16.
17.
Almajan, Gabriela Laura, et al.. (2009). Copper(II) and uranyl(II) complexes with acylthiosemicarbazide: Synthesis, characterization, antibacterial activity and effects on the growth of promyelocytic leukemia cells HL-60. European Journal of Medicinal Chemistry. 44(8). 3323–3329. 30 indexed citations
18.
Roy, Jenny, et al.. (2008). Chemical Synthesis of (S)‐Spiro(estradiol‐17,2′‐[1,4]oxazinan)‐6′‐one Derivatives Bearing Two Levels of Molecular Diversity. European Journal of Organic Chemistry. 2008(14). 2446–2453. 10 indexed citations
19.
Poirier, Donald, Marie Bérubé, Fatima Kamal, & Jenny Roy. (2006). A Dehydrohalogenation Methodology for Synthesizing Terminal Olefins under Mild Conditions. Synthesis. 2006(18). 3085–3091. 7 indexed citations
20.
Roy, Jenny, et al.. (2003). A Novel Pure SERM Achieves Complete Regression of the Majority of Human Breast Cancer Tumors in Nude Mice. Breast Cancer Research and Treatment. 81(3). 223–229. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by René Maltais Breakdown of academic impact, for papers by Mathias Färnegårdh Breakdown of academic impact, for papers by Michael L. Mohler Breakdown of academic impact, for papers by Shankar M. Singh Breakdown of academic impact, for papers by Nigel Vicker Breakdown of academic impact, for papers by Martin Frotscher Breakdown of academic impact, for papers by Tadas S. Vasaitis Breakdown of academic impact, for papers by Mark Salvati Breakdown of academic impact, for papers by Cecil H. Robinson Breakdown of academic impact, for papers by Raju Mohan
Rankless by CCL
2026